SEC Comment Letter 0000000000-23-012572 to ZOOZ Strategy Ltd. (ZOOZ)
ZOOZ Strategy Ltd.
Date: Nov. 16, 2023 · CIK: 0001992818 · Accession: 0000000000-23-012572
AI Filing Summary & Sentiment
Show Raw Text
United States securities and exchange commission logo
November 16, 2023
Boaz Weizer
Chief Executive Officer
ZOOZ Power Ltd.
4B Hamelacha St.
Lod 7152008
Israel
Re:ZOOZ Power Ltd.
Amendment No. 1 to Draft Registration Statement on Form F-4
Submitted November 2, 2023
CIK No. 0001992818
Dear Boaz Weizer:
We have reviewed your amended draft registration statement and have the following
comments.
Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR. If you do not believe a comment applies to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
After reviewing the information you provide in response to this letter and your amended
draft registration statement or filed registration statement, we may have additional
comments. Unless we note otherwise, our references to prior comments are to comments in our
October 13, 2023 letter.
Amendment No. 1 to Draft Registration Statement on Form F-4
Summary
The Business Combination Agreement
Merger Consideration, page 28
1.We note your revised disclosure in response to prior comment 5 explaining how the stock
split will result in 6,000,000 ZOOZ ordinary shares post-Recapitalization. As previously
requested, please clarify your disclosure indicating that the stock split will cause the
implied value of the outstanding ZOOZ ordinary shares to equal $10 per share. That is, it
appears the stock split will only cause the number of outstanding ZOOZ ordinary shares to
equal 6,000,000. Tell us how a stock split of ZOOZ ordinary shares that results in
FirstName LastNameBoaz Weizer
Comapany NameZOOZ Power Ltd.
November 16, 2023 Page 2
FirstName LastNameBoaz Weizer
ZOOZ Power Ltd.
November 16, 2023
Page 2
6,000,000 ZOOZ ordinary shares outstanding can cause an implied value of such shares to
be $10 per share, in light of the trading price of ZOOZ ordinary shares on the TASE. That
is, it appears that $10 per share is the assumed trading price of Keyarch Acquisition
Corporation ordinary shares for which ZOOZ ordinary shares will be exchanged into in
the Business Combination. In other words, it appears the implied value of the 6,000,000
ZOOZ ordinary shares outstanding will be $60,000,000 as a result of the Business
Combination, not the Recapitalization.
Unaudited Pro Forma Condensed Combined Financial Information
Unaudited Condensed Combined Pro Forma Balance Sheet, page 46
2.We note that the consummation of the Business Combination is subject to various
conditions, including that either immediately prior to or upon the Closing, after giving
effect to the Redemption and any receipt of proceeds from any pre-Closing Keyarch
financing, Keyarch shall have net tangible assets of at least $5,000,001. Please tell us how
you meet this condition under each of the No, Interim, and Maximum Redemption
Scenarios.
Unaudited Condensed Combined Pro Forma Statement of Operations, page 52
3.Please disclose the nature of the adjustments labeled as 4(C). In addition, revise to give
effect to the actual redemption on July 20, 2023 as well as the impact of redemptions
under the Interim and Maximum Redemption Scenarios. That is, your pro forma
statements of operations should show the effect on income earned on investment held in
Trust Account from such redemptions as if the redemptions occurred as of the earliest
period presented.
Opinion of Keyarch's Financial Advisor, page 139
4.We note your response to our prior comment 13 and that the assumptions underlying
your provided projections appear to assume significant revenue growth inconsistent with
your historic operating trends. Please revise your disclosure to clearly discuss why the
board believes the assumptions underlying the projections are reasonable. Your revised
disclosure should highlight the relevant factors that could prevent this growth from
occurring.
ZOOZ Power Ltd.
Unaudited Condensed Interim Financial Statements
Notes to the Financial Statements
Note 2 - Significant Accounting Policies:
Revenues, page F-9
5.We note your disclosure that you have one type of performance obligation under your
contracts. Please clarify the nature of the performance obligation. Describe the promises
in your contracts and how you determined that you have a single performance obligation
FirstName LastNameBoaz Weizer
Comapany NameZOOZ Power Ltd.
November 16, 2023 Page 3
FirstName LastName
Boaz Weizer
ZOOZ Power Ltd.
November 16, 2023
Page 3
and what consideration was given to the existence of any other distinct performance
obligation. In this regard, you disclose on page 211 that revenue is also generated from
professional services provided to customers in support of installation, operation, and
maintenance of your products, in addition to the sale of ZOOZTER™-100 products.
Note 6 - Commitments and Contingencies, page F-11
6.We note your disclosure of the amount of the commitment to pay royalties as of June 30,
2023 in response to prior comment 17. As previously requested, please revise to disclose
the total contingent obligation for royalties as of the balance sheet date. That is, we note
that you have committed to pay royalties on any sales of the products up to the amount of
the grants received from Israel Innovation Authority and other participation grants as well
as from collaborations agreements and pilot programs, plus interest at LIBOR with respect
to Israel Government grants and escalating based on the passage of time with respect to
the BIRD grants. Revise to disclose the total amount of grants and funding received to
date, plus interest and escalation, as applicable. Refer to ASC 450-10-50-4(b).
Audited Financial Statements
Notes to the Financial Statements
Note 9 - Commitments and Contingencies, page F-33
7.We note your revised disclosure in response to prior comment 18 of the amounts deducted
from research and development expenses. As previously requested, please reconcile these
amounts to your discussion of the grants and funding received from government grants
and collaborative arrangements in each of the periods presented. That is, we note your
policy that the amounts received were recorded as an offset to research and development
expenses, but the total amount of grants and funding received during each of the periods,
as noted from your discussion, appears to significantly exceed the amounts deducted from
research and development expenses in the table on page F-42. Consider providing us with
a summarized roll forward of your grants and funding account.
Please contact Melissa Walsh at 202-551-3224 or Stephen Krikorian at 202-551-3488 if
you have questions regarding comments on the financial statements and related matters. Please
contact Austin Pattan at 202-551-6756 or Jeff Kauten at 202-551-3447 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Nahal Nellis